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Abstract
High-throughput screening (HTS) is seen as one of the most promising technologies to facilitate
biomedical studies and pharmaceutical discoveries. Although large varieties of in vitro HTS
technologies have opened great opportunities, the speed of improvement has been limited by
lack of advanced tools for in vivo screening on whole complex organisms, such as vertebrates.
To address this issue, a high-throughput platform as a vertebrate total analysis/screening
system (V-TAS) is proposed. This platform consists of two independent parts: an automated
imaging system and an automated microinjection system. These two systems are designed for
general high-content high-throughput pharmaceutical and genetic screens on whole zebrafish
larvae, and therefore, are well-modularized for adapting different situations. Furthermore, to
demonstrate the capability of V-TAS, a screen of lipidoid library for biologics delivery on
thousands of animals was conducted. Very limited damage to the larvae was shown during the
screening. In the end, the author also validated the hits discovered by V-TAS can be applied to
more advanced animal models such as rats, and be more predictable than cell-based assays.
Thesis Supervisor: Mehmet Fatih Yanik
Title: Associate Professor of Electrical Engineering and Computer Science
i
Acknowledgements
I would like to express my deepest gratitude to my advisor, Dr. Mehmet Fatih Yanik, for his
excellent guidance, caring, patience, and providing me with an excellent atmosphere for doing
research. I would like to thank Dr. Hatice Altug, who let me experience the research of
nanotechnology beyond the textbooks and patiently corrected my writing. I would also like to
appreciate Dr. Louis Braida and Dr. Dennis Freeman for guiding my research for the past few
years and helping me to develop my background.
I would like to specially thank Foxconn's founder and CEO, Mr. Terry Gou, who has supported
me throughout my PhD with his mentoring, encouraging and funding. Without him, I would not
have an opportunity to participate in such an exciting venture.
I also thank Chialing Pai and Chihyu Huang, who as my girlfriend and ex- girlfriend, were always
willing to support and give their best suggestions. Many thanks to Peng Shi, Min Huang, Ali
Yanik, Carlos Pardo, Joe Steinmeyer, Paul Tillberg and other co-workers in the laboratory of Dr.
Yanik for helping me on different aspects in the research. My research would not have been
possible without their helps.
Finally, I deeply appreciate and thank my whole family, my parents and my sister. They were
always supportive with their best wishes and wisdom.
ii
TABLE OF CONTENTS
Abstract....................................................................................................................................... i
Acknowledgem ents .................................................................................................................... ii
Table of Contents ....................................................................................................................... iii
Chapter 1: Background and Introduction 001
1-1 Introduction ................................................................................................................... 001
1-2 Background ................................................................................................................... 003
1-3 Chemical Screens of Zebrafish and High-throughput Platform .............................. 005
Figures ........................................................................................................................................ 007
References .................................................................................................................................. 008
Chapter 2: Vertebrate Automated Screening Technology 010
2-1 Introduction and System Setup .................................................................................... 010
2-2 System Perform ance ...................................................................................................... 011
2-3 H ardware/Software Architecture and Operation ...................................................... 014
Figures ........................................................................................................................................ 018
References .............................................................................................................................. 025
Chapter 3: Fully Automated Cellular Resolution Vertebrate Screening
Platform with Parallel Processing 026
3-1 Introduction and System Setup ................................................................................... 026
3-2 M ulti-thread Operation ................................................................................................ 027
3-3 Fluorescence/bright Field Automated Larvae Discriminator ................................... 028
iii
3-4 Identification of Zebrafish Orientation and Position ................................................ 030
3-5 Analysis of Capillary Materials for High Quality Imaging ...................................... 033
3-6 C onclusions.....................................................................................................................035
3-7 Algorithms and Software for Operation Sequence .................................................... 036
Figures ........................................................................................................................................ 037
R eferences .................................................................................................................................. 044
Chapter 4: Vertebrate Automated Microinjection System 045
4-1 Introduction ................................................................................................................... 045
4-2 System Setup...................................................................................................................047
4-3 Im age Processing and R ecognition...............................................................................050
4-4 System H ardw are A rchitecture .................................................................................... 053
4-5 H ealth A ssessm ent ......................................................................................................... 054
Figures ........................................................................................................................................ 055
R eferences .................................................................................................................................. 060
Chapter 5: Screenings: from Cells, Zebrafish to Rodents 062
5-1 Introduction ................................................................................................................... 062
5-2 In vivo Screening of Zebrafish and Validation ........................................................... 063
5-3 V entricle Injection in R ats ............................................................................................ 065
5-4 R odent Prim ary N eural C ells ...................................................................................... 066
5-5 Lipidoids-m R N A Form ulation .................................................................................... 066
5-6 D ot-blot of R odent Brain Tissues ................................................................................ 067
Figures ........................................................................................................................................ 069
iv
R eferences .................................................................................................................................. 072
Chapter 6: Conclusions 073
6-1 Conclusions.....................................................................................................................073
R eferences .................................................................................................................................. 076
Appendix A: CAC Protocol 0309-025-12 for Subcellular Imaging 077
Appendix B: CAC Protocol 0112-008-15 for Microinjection 089
Appendix C: CAC Protocol 1011-126-14 for Rodent Injection 100
Appendix D: Major Publications during Ph.D Studies 108
V
Chapter 1
Introduction and background
1-1 Introduction
The pharmaceutical industry is facing unprecedented productivity challenges
in the recent years. Since 2000, the number of new drug approvals (NDA) by the
FDA is significantly decreasing although the R&D expenditure in pharmaceutical
companies has increased three-fold from 2000 to 2009 [1]. It is believed there is a
huge need for novel methods for drug discovery in order to improve this situation.
Among recent proposed methods, high-throughput screening (HTS) technologies
are taking the lead because of their speed and cost-effective ratio [2].
HTS-based in vitro drug screening assays are widely applied to pharmaceutical
companies because of the increasing number and diversity of compounds made
available by rapid synthesis techniques such as combinatorial chemistry. However,
validating these in vivo preliminary hits made by in vitro drug screening by
mammalian animal models is slow and costly, resulting in a gap in the drug
development process. The zebrafish is a vertebrate model organism that holds a
great potential to bridge this gap [3-11]. In fact, zebrafish represent as one of the
most ideal animal models for in vivo high-throughput screening [12, 13]. The trend
of zebrafish studies is also growing exponentially.
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Although zebrafish have many advantages over other animal models, crucial
problems still exist. First of all, there are very limited automation systems
proposed for this animal model. As an animal model known for its high-
throughput potential, there is a significant need for developing automation
systems to fulfill the potential of this model. For instance, researchers usually
need to precisely orient and immobilize larvae in order to image or manipulate the
animal at the cellular level. Current orientation control methods require
embedding the sample in viscous media such as agar and manually orienting the
fish with forceps. This process is slow and unreliable for high-throughput screens,
which dramatically hinders the capability of high-throughput screening on the
zebrafish. In addition, the samples cannot be rapidly re-oriented once they are
fixed, thus impeding visualization of organs from multiple angles. Furthermore,
manual manipulation of the animal can also increase the uncertainty and
variation. Damage of the larvae can be often observed with incautious operations
as well.
To address those issues, the author proposals an in vivo total
analysis/screening platform (in vivo-TAP). In vivo-TAP consists of two individual
systems: an automated subcellular imaging system [4, 5] and an automated
microinjection system. This platform includes most of important functions needed
for the in vivo screening pipeline on small animal model, such as sorting,
subcellular imaging, high-precision orientation, injection etc. Currently, this
platform has been setup [5]. The author further applied pipelining apparatus to
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minimize the screening cycle [4]. In order to demonstrate the capability of this
platform, the author has successfully performed a screen on a library of
transfection reagents for neural cells and further validated the results via testing
assays on rodent models.
1-2 Background
A one of the most suitable vertebrate animal models for microfluidic
operations, zebrafish (Danio Rerio) facilitates the study of complex processes
on a large scale that cannot be replicated in vitro such as: organ development;
neural degeneration and regeneration; stem cell proliferation and migration;
cardiovascular, immune, endocrine, and nervous system functions; infectious
disease progression; pathogenesis; cancer progression; and tissue specificity
and toxicity of drugs. Several desirable attributes of zebrafish have fueled its
popularity, including the animal's small size, optical transparency, aquatic
habitat, and simplicity of culture. Zebrafish models of several human diseases
have been developed [11, 13-16]. Leading compounds discovered by screening
chemical compound libraries for efficacy in zebrafish disease models have
been useful for pharmaceutical discovery due to the high level of conservation
of drug activity between mammals and zebrafish [9, 17-19]. The availability of
large numbers of mutant strains and genetic manipulations such as gene
overexpression, knockdown, and silencing make zebrafish a powerful model
for genetic studies and for identification of the cellular targets of new
compounds [9, 20]. The significant advantages of zebrafish have fueled
3
exponential growth of its use in experimental investigations over the last two
decades.
Although zebrafish have so many advantages over other animal models,
crucial problems still exist. For instance, researchers usually need to precisely
orient and immobilize larvae in order to image the animal at the cellular level.
Current orientation control methods require embedding the sample in viscous
media such as agar and manually orienting the fish with forceps. This process
is slow and unreliable for high-throughput screens, which dramatically
hinders the capability of high-throughput screening on zebrafish. In addition,
the samples cannot be rapidly re-oriented once they are fixed, thus impeding
visualization of organs from multiple angles.
In order to address those issues, we demonstrate a platform for rapid
manipulation of zebrafish larvae for high-throughput subcellular-resolution
genetic and chemical screen. A complete cycle consisting of loading,
positioning, rotating, sub-cellular resolution confocal imaging, and dispensing
each animal takes less than 16 seconds. Screening hundreds of animals
demonstrates that the system works noninvasively and reliably in the
presence of artifacts such as air bubbles and debris in the growth medium.
On the other hand, except the need for a high-content and high-
throughput imaging technology, injection technology on larvae for material
delivery, gene modification and advanced toxicity assays etc. is a general and
important technique in zebrafish animal model. Conventionally, researchers
need to anesthetize, orient, immobilize with a suction tip and then inject
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manually in order to deliver materials into the animal. The whole process
usually takes 5-10 minutes. Although some researchers have demonstrated
the automated high-throughput microinjection systems for zebrafish embryos
[21], this kind of setup is mainly for material delivery or gene modification
during the early embryonic stage (within 10 hours after fertilization), and
therefore, have very limited applications. In order to achieve precise material
delivery in vivo in high-throughput for wide applications, an automated
microinjection technology for larvae is crucial. With this high-throughput in
vivo microinjection technology, we can enable assays which are hard to
achieve with current technologies, such as large-scale in vivo transfection
reagent screenings, tissue-specific gene modification/transfection, advanced
toxicity assays or cancer cell transplantation and so on.
To sum up, the goal of this work is to build a total analysis/screening
high-throughput platform on a whole vertebrate organism for addressing the
problems mentioned above. The author validated the capability of this
platform with screening on drug libraries and further tested on rodent models.
1-3 Typical chemical screens of zebrafish and high-throughput
platform
To facilitate a dramatic improvement in the throughput and complexity of
zebrafish screens, we developed a platform for rapid manipulation of zebrafish
larvae for imaging and injecting. The automated system allows both genetic and
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pharmaceutical screens, as shown in Fig. 1-2 Chemical screen: Animals are loaded
from a reservoir to the imaging platform, which can be used either to count the
number of animals and/or to perform optical manipulations such as laser
microsurgery. The animals are then dispensed into multiwell plates containing
chemicals to be tested. However, in many cases, chemicals either cannot
penetrate through various endothelial tissue barriers such as blood-brain barrier
[22], thus require to be injected to test drug efficacy and toxicity. Another general
way to transfer chemicals/reagents is via microinjection of zebrafish larva and
embryos. Microinjecting is a time-consuming process which usually takes 5-10
minutes for orienting, immobilizing, positioning and injecting of each larva. Our
platform can facilitate microinjection via the automation of these processes in an
innovative fashion. After incubation/microinjection within chemicals, the animals
are loaded back into the imaging platform to check phenotypes.
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Figure 1-1. A historical perspective of zebrafish research.
Chemical/drug Screens
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Figure 1-2. Flow diagram for chemical and drug screens from loading, imaging,
material delivering to image for phenotyping.
7
Figures
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
V 
MW
References
1. Macarron, R., et al., Impact of high-throughput screening in biomedical research.
Nat Rev Drug Discov, 2011. 10(3): p. 188-95.
2. Mayr, L.M. and D. Bojanic, Novel trends in high-throughput screening. Curr Opin
Pharmacol, 2009. 9(5): p. 580-8.
3. Lieschke, G.J. and P.D. Currie, Animal models of human disease: zebrafish swim
into view. Nat Rev Genet, 2007. 8(5): p. 353-67.
4. Chang, T.Y., et al., Fully automated cellular-resolution vertebrate screening
platform with parallel animal processing. Lab Chip, 2012. 12(4): p. 711-6.
5. Pardo-Martin, C., et al., High-throughput in vivo vertebrate screening. Nat
Methods, 2010. 7(8): p. 634-6.
6. Sukardi, H., et al., Zebrafish for drug toxicity screening: bridging the in vitro cell-
based models and in vivo mammalian models. Expert Opin Drug Metab Toxicol,
2011. 7(5): p. 579-89.
7. Lam, S.H., et al., Zebrafish whole-adult-organism chemogenomics for large-scale
predictive and discovery chemical biology. PLoS Genet, 2008. 4(7): p. e1000121.
8. Brittijn, S.A., et al., Zebrafish development and regeneration: new tools for
biomedical research. Int J Dev Biol, 2009. 53(5-6): p. 835-50.
9. Barros, T.P., et al., Zebrafish: an emerging technology for in vivo pharmacological
assessment to identify potential safety liabilities in early drug discovery. Br J
Pharmacol, 2008. 154(7): p. 1400-13.
10. Parng, C., et al., Zebrafish: a preclinical model for drug screening. Assay Drug Dev
Technol, 2002. 1(1 Pt 1): p. 41-8.
11. Rubinstein, A.L., Zebrafish: From disease modeling to drug discovery. Current
Opinion in Drug Discovery & Development, 2003. 6(2): p. 218-223.
12. Zon, L.I. and R.T. Peterson, In vivo drug discovery in the zebrafish. Nat Rev Drug
Discov, 2005. 4(1): p. 35-44.
13. Langheinrich, U., Zebrafish: a new model on the pharmaceutical catwalk.
Bioessays, 2003. 25(9): p. 904-12.
14. McGrath, P. and C.Q. Li, Zebrafish: a predictive model for assessing drug-induced
toxicity. Drug Discov Today, 2008. 13(9-10): p. 394-401.
8
15. Stoletov, K. and R. Klemke, Catch of the day: zebrafish as a human cancer model.
Oncogene, 2008. 27(33): p. 4509-20.
16. Kim, S.U. and J. de Vellis, Stem cell-based cell therapy in neurological diseases: a
review. J Neurosci Res, 2009. 87(10): p. 2183-200.
17. Jette, C.A., et al., BIM and other BCL-2 family proteins exhibit cross-species
conservation offunction between zebrafish and mammals. Cell Death Differ, 2008.
15(6): p. 1063-72.
18. Kokel, D. and R.T. Peterson, Chemobehavioural phenomics and behaviour-based
psychiatric drug discovery in the zebrafish. Brief Funct Genomic Proteomic, 2008.
7(6): p. 483-90.
19. Zimmerman, J.E., et al., Conservation of sleep: insights from non-mammalian
model systems. Trends Neurosci, 2008. 31(7): p. 371-6.
20. Whitehead, K.A., R. Langer, and D.G. Anderson, Knocking down barriers: advances
in siRNA delivery. Nat Rev Drug Discov, 2009. 8(2): p. 129-38.
21. Wang, W., et al., A fully automated robotic system for microinjection of zebrafish
embryos. PLoS One, 2007. 2(9): p. e862.
22. Gabathuler, R., Approaches to transport therapeutic drugs across the blood-brain
barrier to treat brain diseases. Neurobiol Dis, 2010. 37(1): p. 48-57.
9
Chapter 2
Setup of Vertebrate Automated
Screening Technology (VAST)
2-1 Introduction and System Setup
The automated system for vertebrate high-throughput screening allows both
genetic and pharmaceutical screens. Specimens can be repositioned and rotated
on the fly, eliminating the need for manual handling and 1-phenyl 2-thiourea
(PTU) treatment. Each screening cycle of the machine comprises the following
major steps: loading, detection, positioning, orienting and focusing, imaging, and
dispensing (Figure 2-1).
During loading, the system extracts larvae either from a multiwell plate or a
reservoir. Fluid is driven by a computer-controlled syringe pump. A high-speed
photodetection system composed of a photodiode and two LEDs discerns the
entry of larvae into the loading tube. The photodiode senses transmitted light
from one LED and scattered light from the other LED. By simultaneously
monitoring both the transmission and scattering signals, the system discriminates
the passage of a larva from air bubbles and debris with 100% reliability (n = 1000).
After loading and photodetection, the larva transits from the larger loading tube
into an index-matched capillary within the field-of-view (FOV) of an optical
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imaging and manipulation subsystem. The capillary has a refractive index similar
to water, allowing the use of high numerical-aperture (NA) water-immersion
objectives that require short working distances. Using a fast camera and an
automated image processing algorithm, the larva is coarsely positioned by the
syringe pump within the FOV. Next, a 3-axis stage automatically moves the
capillary assembly so that the larva's head is precisely positioned to the center of
the FOV. The larva is then rotationally oriented by a pair of stepper motors. Thus,
larva can be arbitrarily positioned and oriented in the microscope's FOV. At the
end of the screening cycle, animals can be dispensed back into either individual
wells or larger containers by executing the loading process in reverse.
2-2 System Performance
The optical imaging and manipulation subsystem includes two microscope
objectives; an upright, high-resolution water-immersion objective and an inverted
air objective. This allows both wide-field fluorescence imaging and high-resolution
confocal-microscopy. Figure 2-2a shows confocal images of a larva oriented at two
different angles to visualize the midline crossing of the Mauthner motor neuron
axons that project into spinal cord. The midline crossing is only visible when
directly observed from the hindbrain (O in the figure). At less favorable
orientations, the structure is obscured. We performed an illustrative screen on a
similar midline crossing of retinal axon projections to the optic tectum (Figure 2-
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2b). This mutant screen had previously led to the discovery of robo2 mutant with
retinal axon misguidance [1]. Using our system, we were able to distinguish wild-
types from mutants with a sensitivity of 100% and specificity of 98.8% for a 96-
well plate with 83 randomly seeded mutants. Thus, this mutant screen can be
used for large-scale pharmaceutical screens for discovery of small molecules that
rescue such misguidance.
In conjunction with the sample positioning and orientation capability, the
optical system also allows subcellular-precision laser manipulations such as
localized activation of fluorescent reporters and ion channels, uncaging of
compounds, and femtosecond laser microsurgery. We show in Figure 2-3a an
example of how the system can be used to study neuronal regeneration following
injury by laser microsurgery. The lateral-neuron axon fiber bundle projecting along
the trunk of a larva is visible when the larva is laterally oriented. We perform
subcellular-precision laser axotomy by focusing near-infrared femtosecond laser
pulses [2]. The surgery function is semi-automated to achieve high throughput:
The user selects a cell body by clicking on a graphical user interface. An algorithm
estimates the distance from the cell body to the point of axotomy along the axon.
The position stage automatically moves the axonal region to be axotomized to the
focal spot of the laser. The regenerating axonal fibers are shown at 18 and 24
hours post-axotomy in Figure 2-3a. The laser pulses were delivered with high
precision (1.7 pim), and the subsequent response of the tissue to the laser (i.e.
immediate retraction of nerve fibers) showed variability (± 5.5 ptm) (Figure 2-3b).
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Collateral damage was insignificant: 100% of the animals recovered from surgery
within 30 minutes with no apparent morphological abnormality, and 100% of the
animals survived 24 hours post surgery.
A complete cycle of loading, positioning, subcellular-resolution imaging, and
dispensing an animal takes less than 16 seconds. The laser surgery operation
requires an additional 2 seconds. Screening an entire multiwell plate took 31.85
minutes with an average 19.9 seconds-well1 , which includes the additional
interval for retracting, moving and inserting the loading apparatus, and sealing the
wells. Performed manually, assays of similar complexity require about 10 minutes
per animal, and the error rate is much higher.
We have performed health assessment on n = 450 larvae screened at 2 dpf at
three different initial aspiration rates (Fig. 2-4a). The health assessment was based
on both functional and morphological criteria measured at t = 0+, 12, 16, 20, 24,
28, 32, and 36 hours. Functional criteria included visual confirmation of normal
heartbeat and reflex response to touch stimuli. Morphological criteria included
bending (i.e. lordosis, kyphosis, and scoliosis) and craniofacial abnormalities. At all
flow rates, heartbeat and touch response matched those of controls. Tearing of
yolk was never observed (n = 450). At the highest initial flow rate of 330 p1l-s1, 2.0
% of the animals exhibited morphological abnormality. When the loading speed is
slightly slower, all health criteria matched those of controls (Fig. 2-4a). Post
manipulation developmental delay was measured by monitoring the time of
appearance of the swimming bladder. There was no significant difference with
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single-tailed t-test (P = 0.94) between the development of larvae that were
manipulated by the system and control animals, even at the highest flow rates
(Fig. 2-4b). Among the different larval age groups tested (i.e. 2-7 dpf, n > 100 per
age), no statistically significant difference in health assessment was observed in
comparison to the results for 2 dpf larvae (see 4-5 Health Assessment).
2-3 Hardware/Software Architecture and Operation
Imaging and Laser Axotomy
The imaging system (Fig. 2-1) consists of a dual (upright/inverted) microscope
(Eclipse Ti, Nikon (inverted), Nikon 90i Digital Imaging Head (upright)) with two
light sources (Mercury lamp, Nikon). The upright microscope's top port is
equipped with a multi-beam laser confocal scanning head (Infinity3, VisiTech) with
a 1004 x 1002 pixel EMCCD camera (iXon+885, Andor Technology) for high-speed
confocal imaging. For high-speed image sectioning, a piezo actuator with 400 pm
travel distance (P-725 PIFOC, Physik Instrumente) holds either a 10x, 20X, or 40x
water immersion lens (Nikon). A tunable femto-second laser (Mai Tai, Spectra-
Physics Lasers) is guided to the upright microscope for laser axotomy. A high-
speed CCD camera (GX-1050, Prosilica) is connected to the side port of the
inverted microscope for larva detection, position and rotation.
Capillary stage
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Two precision stepping motors (KP35FM2-044, Japan Servo Co.) hold a capillary
along its axis of rotation as shown in Fig. 1. The motors are controlled by a
microstepping driver (BSD-02LH, Interinar Electronics). The motor and capillary
assembly is mounted on a 3-axis precision stage (MP-200, Sutter Instrument) with
0.04 Ipm resolution along each axis.
High-Speed photodetection
The photodetection system (Fig. 2-1) consists of a photodiode IC (OPT301, Texas
Instruments) and two LEDs (Cree Inc) aligned in transmission and reflection
configurations as shown. The photodiode IC contains an integrated amplifier.
Multiwell plate/ reservoir loading
The system can load larvae from reservoirs or multiwell plates (Fig. 2-1). The
multiwell plate loading stage is comprised of 3 linear precision motors (RCA2,
Intelligent Actuators). The motors are controlled by RACON 20/30 drivers
(Intelligent Actuators). The loading head consists of two tubes (New England Small
Tubing Inc.) inserted into a silicone rubber block. The silicon rubber block is
pressed (by the loading stage motor) against the top of the multiwell plate to seal
the wells. One tube aspirates the larva from the sealed well, while the other tube
injects water.
Fluidic Pumps and Switches
15
Larvae are delivered to the capillary under the objective lens through a syringe
pump (Carvo XLP6000, Tecan Systems). Two fluidic valves (075P2NC12, Bio-Chem
Fluidics) are used to switch the flow between the reservoirs and multiwell plate by
pinching the silicone tubing (1/32" ID x 3/32" OD, Bio-Chem Fluidics).
Computer Interface and Control
Two NiDAQ input/output data cards (PCI-6512 and PCI-6259, National Instrument)
are mounted in a DELL OptiPlex computer to control the fluidic valves, stepping
motors, and reading out the voltage across the photodetector. The control
software is written in Matlab.
Algorithm for Operation Sequence
The detailed algorithm for operation sequence of the system is shown in the
flowchart of Figure 2-5. The rectangles, parallelogram, and rhomboids represent
the actions, measurements, and conditionals, respectively.
The system starts by initializing syringe pumps, cameras, lamps, shutters, position
stages, and motors. The fluidic valves (Fig. 2-1) are switched to the source of fish
i.e. either multiwell plate or fish reservoir. The larva is aspirated from the selected
source at a constant rate of acceleration of 42 Id/s2 up to a maximum speed of 330
pJ/s. The photodetector is continuously sampled at 2 kHz rate via the NiDAQ PCI-
6259 card until the intensity reading crosses a pre-determined threshold (the
value of threshold is calibrated in advance by trial and error). Upon detection of
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the larva the fluidic valve is switched to the water reservoir if the larva is being
loaded from the fish reservoir. The aspiration rate is subsequently decreased to 83
l/s to avoid damaging the larva at the entrance of the capillary. The high-speed
CCD at the bottom port is continuously reading at 100 frames/second. The pixel
intensity is averaged over the entire field-of-view, and compared to a pre-
determined threshold (Value of threshold is calibrated in advance by trial and
error). When average pixel intensity drops below the threshold, the aspiration is
stopped.
The capillary is then rotated via the motors until the larva is at the desired
orientation. A large field-of-view image of the gross morphology of the larva is
acquired and stored by the CCD at the bottom port. The motorized shutter of the
inverted microscope (i.e. bottom shutters) is closed while that of upright
microscope (top shutters) is opened. The image acquisition is switched from the
bottom CCD to either the top CCD or the high-speed scanning confocal head
equipped with EMCCD. Guided by fluorescence imaging, the region of interest is
located. Either confocal stacks or wide-field fluorescence images are acquired. The
top shutter is closed, and the bottom shutter opened. The image acquisition is
switched to the bottom port. The system is now ready for the next cycle of
operation.
Figures
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PD High-speed confocal
CCD
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Figure 2-1. Zebrafish manipulation and imaging platform. Larvae are
automatically loaded to the system from either reservoirs or a multi-well plates.
Reservoirs of larvae and water are connected to the system via fluidic valves. A
bubble mixer prevents settling of the larvae to the bottom of the reservoir. The
multiwell plate sits on a motorized x-y stage, which positions individual wells below
a larva-loading and a water-supply tube (diameters 1.0 and 0.2 mm, respectively),
both held by a silicone rubber block. The silicon rubber block seals the well surfaces
as a piston moves the loading and supply tubes into the wells. A photodetection
system including two LEDs and one high-speed photodiode in transmission and
reflection configurations discriminates the passage of a larva from air bubbles and
debris with 100% reliability (n = 1000). Two stepping motors hold a capillary of
diameter 800 pm along its axis of rotation. The motor and capillary assembly is
mounted on a 3-axis position stage (not shown) and held below an upright either
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10x (NA = 0.5) or 20x (NA = 1.0) or 40x (NA = 0.8) water-immersion objective lens
for confocal imaging and an inverted 10x air objective lens for bright-field imaging.
A multifocal confocal head with a cooled electron-multiplying (EM) CCD camera is
connected to the microscope's upright port for high-speed confocal fluorescence
imaging. A second upright cooled camera with large-area CCD allows wide-field
fluorescence imaging. A high-speed CCD camera connected to the inverted port
allows rapid bright-field detection and positioning of larvae. A femtosecond laser
beam used for microsurgery is directed to the upper beam path by a dichroic filter
and focused on the sample through the objective.
aII
Figure 2-2. Orientation, imaging, and screening of zebrafish larvae. (a) Schematic
of Mauthner cell neuroanatomy on the left showing the midline crossing of
Mauthner axons. Confocal images of EGFP expressing Mauthner cells at 0, 159,
and 459. The midline crossing of Mauthner axons in the hindbrain is visible only in
the 09 view. Scale bar 150 pm (50 pm for insets). (b) An illustrative genetic screen.
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GFP labeled axons of retinal ganglion neurons projecting to the optic tectum fail to
exhibit proper midline crossing in homozygous astray (ast.I+) zebrafish, while the
projections are normal in heterozygous (ast.-) zebrafish. Genotypically
homozygous ast~'' and ast.l*fish were crossed to generate ast.'- larvae. A 96-well
plate was randomly and partially populated with the heterozygous ast.- progeny.
The rest of the wells were populated with the homozygous progeny of ast.+fish. A
blind screen was performed by loading the animals from multi-well plates and
orienting them to visualize midline crossing as in part (a) by a 10x (NA = 0.5)
objective lens with long depth-of-focus in wide-field fluorescence imaging mode.
Animals were blindly classified according to the observed phenotype. White arrows
in the representative images of the range of phenotypes screened point to the
misguided projections that led to the indicated phenotypic classifications. True
positive rates of 100% and 98.80% were achieved for identification of ast.'- and
ast.+ animals, respectively. The 1.20%false negative error in identification of ast.l.
animals was due to the rare cases of mutants with strong phenotypic similarity to
wild type. Scale bar 150 pm.
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Figure 2-3. Subcellular femtosecond laser microsurgery and subsequent neuronal
regeneration. (a) Femtosecond laser micro-axotomy of lateral-neuron axon fibers
in a 3 dpf larva laterally oriented by the system. Wide-field fluorescence images
are shown at 3 sec pre-axotomy, and 5 sec, 18 hours, and 24 hours post- axotomy
respectively. The axon fiber is cut 850 pm distance from the soma using ultrashort
laser pulses with 780 nm wavelength, 100 fs duration, 12.7 nJ pulse energy, 80
MHz repetition rate, and 10 ms long pulse train focused by a 20x NA =1.0 objective
lens. (b) Statistics of laser cut sizes were quantified with 40x NA = 0.8 objective
lens. Surgeries were repeated on n = 30 animals with 100% success rate. The laser
was focused with a precision higher than 1.7 pm. The results were measured 5
seconds after surgery and cuts had an average size of 8.1 ± 5.5 pm. Scale bar 75
pm.
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Figure 2-4. Quantitative assessment of throughput and animal health. (a)
Assessment of animal health. The syringe was operated at three different initial
aspiration rates of 165, 250, and 330 Al-s-1 for loading 2 dpf larvae from
multiwells. n = 450 larvae in total were anesthetized with 0.20 mg-ml-1 Tricaine,
loaded, and dispensed from the platform. A control group of n = 150 larvae from
the same breed were similarly anesthetized. The survival rate (blue column) at the
maximum initial flow rate of 330 pl-s-1 was 98.0%. The health assessment was
based on both functional and morphological criteria measured at t = 0+, 12, 16, 20,
24, 28, 32, 36 hours: Functional criteria included visual confirmation of normal
heartbeat, and reflex response to touch stimuli. Morphology criteria included
bending (i.e. lordosis, kyphosis, and scoliosis) and craniofacial abnormalities. Our
criteria included those injuries even if the animals regenerated later. At all flow
rates shown in Fig. 5b, heartbeat and touch response matched those of controls,
and tearing of yolk was never observed (n = 450). At the highest initial flow rate
(330 pl-s-1), only 2.0% of the animals exhibited morphological abnormality.
Furthermore, when the loading speed is slightly slower (increasing the screening
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ba
time approximately only by 1 second), all health criteria matched those of the
controls. (b) The appearance time of swimming bladder showed no significant
variation between experiments (blue line, n = 50) and controls (red line, n = 50),
indicating no developmental delay. Experiment was repeated 3 times.
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Figure 2-5. Flowchart showing the algorithm for the operation sequence of the
system.
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Chapter 3
Pipelining of processes and
optimization of VAST
3-1 System Setup
In order to improve timing and reliability of VAST system, we demonstrated the
multi-thread VAST system loads larvae automatically from a 96-well nylon mesh
plate that fits into a matching 96-well tray (MultiScreen-Mesh Plate, Millipore
Inc.). The multiwell plate is brought into position by a three-axis motor stage
(RCA2, Intelligent Actuators). The mesh-filter insert allows easy transfer of larvae.
In order to keep the water level constant, two tubes separately aspirate and
dispense water (Figure 3-1 insert A) via the syringe pump. Larvae are detected as
they pass through the high-speed zebrafish discriminator, which distinguishes
larvae from air bubbles and debris and also differentiates fluorescent from non-
fluorescent larvae. The design of the zebrafish discriminator is discussed in detail
below. Two high-precision step motors (KP35FM2-044, Japan Servo Co.) hold an
ultra-thin glass capillary along its axis of rotation. The capillary has an outer
diameter of 700 pm and a wall thickness of 10 ptm (BGCT 0.7, Capillary Tube
Supplies) and is immersed in a water bath to minimize the index of refraction
mismatch. The assembly (i.e. motors, capillary and water bath) is mounted on a
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three-axis position stage (MPC-200, Sutter Instrument) and held between an
upright microscope for epi-fluorescence (and confocal) imaging and an inverted
microscope for bright-field imaging. The inverted microscope is connected to a
high-speed CCD (GX-1050, Prosilica) and is primarily used to detect, position, and
rotate the larvae. A high-speed confocal head (Infinity 3, VisiTech Inc.) with a
cooled EM-CCD (iXon+885, Andor Technology) is used for confocal imaging. The
fluidic elements are controlled by three pinch valves (075P2NC12, Bio-Chem
Fluidics) and three computerized syringe pumps (XLP 6000, Tecan). Fluidic
components are connected through silicone tubing (0.8 mm inner diameter, Bio-
Chem Fluidics). The entire system is controlled via a code written in MATLAB.
3-2 Multi-thread Operation
The multi-thread VAST system simultaneously performs three independent
operations to enable parallel processing of multiple fish; loading, imaging, and
unloading. At the beginning of each cycle, a larva is acquired from a multiwell
plate by syringe pump 1 and the zebrafish discriminator is activated to distinguish
the contents of the flow (i.e. larvae versus debris or bubbles). After the
discriminator detects a larva, pinch valve 1 is opened and syringe pump 1 is
stopped, allowing the larva to transit from the loading module to the imaging
module. The larva is transported into the imaging module via syringe pump 2 after
the flow direction is changed by switching pinch valves 2 and 3. The loading
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module continuously repeats these steps and each loading cycle takes 4 seconds
to complete. In the imaging module, the larva is automatically positioned, rotated,
and imaged inside the capillary, which takes 9.6 seconds on average. The timing
for imaging was calculated for a single wide-field fluorescence acquisition with a
300 ms exposure time. The larva is then moved to the unloading module and a
new larva is transported into the capillary from the loading module. The larva in
the unloading module, (held between valve 3 and the imaging module), is then
transferred into its corresponding well of the output multiwell plate. Each
unloading cycle takes 3.4 seconds and dispenses 500 ptL of medium with a flow
rate of 165 p.L/sec. Timing analysis is based on trials of n=192 animals. As reported
previously, over 98% of larvae imaged by VAST survive and develop without
noticeable morphological abnormalities [1]. By multi-threading the loading,
imaging and unloading operations, throughput becomes limited only by the
slowest operation (i.e. the imaging step; 9.6 seconds), rather than by the total
time required to carry out all processes (Figure 3-2).
3-3 Fluorescence/bright-field automated zebrafish discriminator
A low-cost, high-performance discriminator (Figure 3-3a) is used to distinguish
larvae from debris and air bubbles and to separate fluorescent and non-
fluorescent larvae. The discriminator is formed by a bright-field photodetection
system and a fluorescence-activated larva sorter. The bright-field photodetection
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system is comprised of an integrated photodiode and an amplifier chip (OPT301,
Texas Instruments) and two LEDs aligned in transmission and refraction/scattering
configurations. The fluorescence-activated sorter consists of an epi-fluorescence
detection system with a GFP filter set, a 1oX lens, a photo-multiplier tube (PMT),
and a mercury light source. By simultaneously measuring transmitted light and
refracted/scattered light at different wavelengths, this device can reliably
discriminate between larvae, debris, and air bubbles based on the
refraction/transmission ratio of different objects (Figure 3-3b). The transmitted
light can largely pass through the fluidic tube when the tube is filled with solution.
When an object or bubble crosses the light path, the light is
absorbed/refracted/scattered and therefore the transmission light intensity
received by the photodiode decreases. A live larva tends to absorb light more than
scattering it, while a dead larva, debris, or bubble tend to scatter light more than
transmit it. To balance the scattered and transmitted light intensity on the
detector, we use two LEDs where one is in the transmission path and the other is
in the orthogonal scattering path. LEDs with different emission colors are used to
aid the alignment of the refraction/transmission ratio. Although the scattered light
intensity is significantly lower, the intensity of the LEDs did not require any tuning
because of the significant difference in the spectral responsivity of the photodiode
to the LEDs' colors. Such discrimination of multicellular organisms has traditionally
been performed with more complicated setups and image processing algorithms.
The reliability of our discriminator was tested under a variety of flow rates,
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ranging from 165 iL/sec to 495 pL/sec (Figure 3-3c). For the flow rates that we
use in screening (330 ptL/sec), the reliability is near 100 %.
3-4 Identification of zebrafish orientation and position
A key step in the design of VAST is the automation of the fine positioning of the
region of interest (ROI) within the relatively small field-of-view (FOV) of the high
power objective lenses used for cellular-resolution imaging. To accurately and
consistently image the same ROI across many larvae, it is necessary to precisely
control both position along the length of the capillary and orientation/rotation
around the fixed axis of the capillary. Due to the phenotypic variations that can
occur in large-scale genetic and chemical screens, a reliable and flexible algorithm
is crucial.
Our algorithm works through a four-step process; coarse positioning of the larva
under the FOV, calculation of the direction of its entry into the capillary,
identification of its orientation and rotation, and fine positioning of the ROI within
the FOV of the high power objective lens.
The coarse positioning of the larvae in the center of the FOV is done through a
closed loop feedback between the CCD imaging the FOV and the computer-
controlled syringe pump as previously described [1].
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Larvae can
reason, the
before any
f(x) for the
orthogonal
the larvae
normalized
enter the capillary in either a head- or tail-first orientation. For this
longitudinal (head vs. tail) orientation of the larvae has to be identified
image processing steps are performed. A 1D pixel intensity profile
fish can be computed by summing the pixel intensities across the axis
to the main tube axis. The center of mass (of pixel intensities), CM, of
is computed by summing the position values weighted by the
1D intensity profile.
n=X1 f(x)xCM = E
C =1 f(x)
The largest intensity variation between the zebrafish and surrounding
water/tubing occurs at the very tip of the head, xO, which is identified by finding
the position of maximum value of f' , the derivative of the 1D intensity profile. The
center of mass falls in the upper part of the abdomen, and therefore the
orientation of the larvae can be found by comparing the geometrical center to the
center of mass of the fish.
1,
D =0,
-1,P
CM - x0 > 0
CM -xo = 0
CM - xO < 0
Where D = 1 (D = -1) means that the head is towards left (right).
We next identify the lateral orientation of the larva. Due to the anatomical
symmetry and optical transparency of the larvae, it is unreliable to identify the
lateral orientation based only on the ventral and dorsal views (Figure 3-4a).
Instead, we acquire a series of 2D images of the larva f(x,y) at a constant frame
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rate of 180 frames per second (fps) while rotating the capillary 360 degrees at a
constant rotation speed at 2 sec/cycle (Figure 3-4b). Using the frame acquisition
rate and rotation speed, a rotation angle is assigned for each acquired frame. We
then compute the cross correlation [2], CC, between each frame and predefined
template intensity distributions t(xy) of age-matched larvae imaged at dorsal and
lateral views using the following relationship:
(( x~y[f(x, y) - fu v[t(x - u, y - v) - uvCC(f, t) = max y[f(x ) - [t(x - u, y - v) - u1
Where fu,v and fu,v are the average pixel values for the image and template,
respectively. The cross-correlation with the dorsal template yields two narrow
peaks at the dorsal and ventral orientations (Figure 3-4c). However, these peaks
alone are insufficient to distinguish between dorsal and ventral sides. The cross-
correlation with the lateral template yields a single wider peak that identifies the
right versus left side of the fish. This knowledge of left/right orientation and the
direction of rotation are then used to differentiate which peaks from the dorsal
template corresponds to the ventral vs. dorsal orientations. To handle phenotypic
variation across larvae, we have constructed a collection of templates for larvae
under the typical morphological abnormalities (e.g. pericardial edema). When the
maximum cross correlation between the templates and the larva does not exceed
a user defined minimum, our algorithm looks through this collection of templates
and recalculates the orientation using the template with the highest correlation. If
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the cross correlation does not reach a user-defined threshold for any template,
the larva is discarded. The reliability of the orientation algorithm is 99 % (n=100
larvae).
Once the dorsal, ventral, and lateral orientations have been identified, the larva is
automatically rotated for imaging at the predefined angle specified by the user
(e.g. dorsally to image the brain, ventrally to image the heart and brachial arches,
obliquely to image the pancreas). At this orientation, the ROI is defined by
matching the larva to a third template of aged-matched larvae at the desired
angle which contains the location of the ROI.
3-5 Analysis of capillary materials for high- quality imaging
Confocal imaging necessitates both low autofluorescence and low optical
aberrations. Since larvae are imaged through a capillary in VAST, the choice of
capillary material is a critical factor in achieving distortion-free, low-background,
high-resolution imaging. A previous study [3] reported that Teflon tubes offer
optimal quality for bright-field imaging of larvae within capillaries, due to the
matched refractive index with water. However, limited quantitative data has been
reported for fluorescence imaging, which is crucial for most experiments.
Polymers such as PTFE (polytetrafluoroethylene) and FEP (fluorinated ethylene
propylene), two types of Teflon, cause significant autofluorescence. This
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dramatically decreases the signal-to-noise ratio (SNR) and lowers the quality of
fluorescent images. On the other hand, glass capillaries with ultra-low
autofluorescence and extinction coefficients are not refractive index-matched to
the surrounding water, which can create distortions and lead to decreased
confocality and axial resolutions.
We have tested four capillaries of different materials and thicknesses and
quantitatively evaluated the point-spread functions (PSF) of the resultant confocal
images. GFP-tagged fluorescent micro beads (0.2 pm in diameter) were mixed in 2
% Type IV optical agarose (Sigma, A3643) to avoid Brownian motion. The beads
were then imaged with a multifocal confocal system with pinhole size of 30 Im,
through a 100x 1.1 NA water dipping objective (Nikon Instruments). The beads
trapped within the agar mold (index matched to water) were imaged either
without any intervening glass,inside a PTFE capillary with a wall thickness of 250
ptm (Zeus Inc.), inside an FEP capillary with a wall thickness of 150 Im (Zeus Inc.),
inside a borosilicate capillary with a wall thickness of 170 Im (Wale Apparatus
Co.), or within an ultrathin borosilicate capillary tube with a wall thickness of 10
Im (Capillary Tube Supplies Ltd.). Figure 3-5a shows a cross-section in the radial
and axial planes through the center of a bead for each of the conditions.
We computed the axial full-width half-maximum (FWHM) of the PSFs without a
capillary and when using the FEP, 170 im thick borosilicate, and the 10 pim thick
borosilicate capillaries. The FWHMs were 1.2 pm, 1.4 im, 2.6 jim and 1.1 jim,
respectively (Figure 3-5b). Due to the optical aberrations that cause non-Gaussian
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like PSFs on the PTFE capillary, we were unable to compute a FWHM. Importantly,
our analysis shows that the 10 pm thick borosilicate capillary produces
significantly less image distortion than the Teflon capillaries with refractive
indexes closer to water. Furthermore, our autofluorescence analysis demonstrates
that, unlike borosilicate, both types of Teflon (i.e. PTFE and FEP) cause significant
autofluorescence (Figure 3-5c). Thus, we conclude the ultrathin (10 plm thick)
borosilicate capillary is the most appropriate choice for high-resolution confocal
imaging.
3-6 Conclusions
Here, we have demonstrated a fully automated multi-threaded vertebrate
screening platform. To significantly increase throughput, we modularized the
system into three independent sections that can process multiple zebrafish in
parallel. In this configuration, system throughput is limited only by the image
acquisition speed rather than by the speeds of fluidic and mechanical processes. A
discriminator differentiates the entry of a fluorescent larva from non-fluorescent
larva, air bubbles, and small debris. A simple and highly reliable algorithm is
implemented for automated identification of the position and rotational angle of
the larva. Furthermore, to identify the best capillary materials for confocal and
fluorescence imaging, we analyzed various capillaries measuring their PSFs and
autofluorescence. We showed that ultra-thin borosilicate capillaries (with wall
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thickness of 10 prm) provide the highest-resolution distortion-free low-background
images.
3-7 Algorithm and Software for Operation Sequence
The detailed algorithm for the operation sequence of the system is shown in the
flowchart of the Figure 3-6. The control software is written in Matlab.
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Figure 3-1 Multi-thread Vertebrate Automated Screening Technology (VAST). The
platform consists of three subsystems that operate simultaneously: loading,
imaging, and unloading. Larvae are automatically loaded to the platform from
individual wells of a mesh-filter multiwell plate positioned by a motorized x-y
stage. The mesh-filter insert allows easy transfer of larvae into the system. In
order to maintain the water level, a circulation device is set nearby the loading
nozzle (inset A). A zebrafish discriminator with a brightfield and a fluorescence
photodetection system (inset B) discriminates the passage of fluorescent larvae
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from non-fluorescent ones, air bubbles and debris. Two step motors hold a
capillary immersed in a water bath along its axis of rotation; this assembly is
mounted on a three-axis position stage (not shown) and held between an upright
microscope and an inverted microscope. A multifocal confocal head with a cooled
electron-multiplying charge-coupled device (EM-CCD) camera and a second large-
area charge-coupled device (CCD) are used for high-speed confocal and wide-field
fluorescence imaging, respectively. A high-speed CCD camera connected to the
inverted microscope allows rapid bright-field imaging for positioning and orienting
the larvae.
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Figure 3-2 Timings of multi-thread processing of zebrafish. Blue, red, and green
bars indicate the processes comprising loading, imaging, and unloading,
respectively. (a) The time required for each handling step (n = 192). (b) Multi-
thread operation: The system simultaneously performs loading, imaging, and
unloading operations with three different larvae. As a result, the overall
processing time is dictated solely by the duration of the slowest process (i.e.
positioning + imaging; 9.6 sec), not by the total duration of all processes.
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Figure 3-3 Zebrafish discriminator. (a) Schematic representation of the zebrafish
discriminator. The system is composed of a bright-field discrimination system and
a fluorescence-activated zebrafish sorter. (b) Schematic representation of the
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Figure 3-4 Identification of the angle and position of larvae. (a) Dorsally and
ventrally oriented larvae. Red arrows indicate the dominant morphological
features for distinguishing dorsally vs. ventrally views. It is too difficult to reliably
determine the larva's orientation based solely on comparisons with dorsal and
ventral reference images. (b) The larva is rotated along its longitudinal axis
through a full 360* and snapshots are acquired at two degree increments at 180
frames per second. (c) The system then correlates the images with a library of
prerecorded dorsal and lateral images from stage-matched control larvae (inset).
The blue and red curves in the radar chart are results of the image correlations
with the dorsal and lateral templates. The blue, green, and red arrows indicate the
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orientations of maximum correlations with the dorsally, ventrally and laterally
orientated templates, respectively. The reliability of the algorithm is 99 % (n=100
larvae)
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Figure 3-5 Analysis of capillary materials for distortion-free low-background high-
resolution imaging. (a) From left to right, the point-spread functions (PSF) with
different materials/conditions; no capillary, PTFE capillary, FEP capillary,
borosilicate glass capillary, and ultra-thin borosilicate glass capillary. The wall
thicknesses of capillaries are 250 Vm, 150 pm, 170 pm and 10 pm, respectively
(shown in brackets). The ultra-thin glass capillary produces the least image
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distortion. Scale bar is 1 pm. (b) Radial (blue) and axial (red) resolutions of
candidate materials. PTFE was not included due to the significant non-Gaussian
PSF it produces. (c) Autofluorescence analysis of candidate materials. PTFE and
FEP capillaries cause significant autofluorescence.
Figure 3-6 Flowchart showing the algorithm for the operation sequence of the
system. Rounded rectangles show the initialization and endpoints of the flow
chart. Square boxes show processing steps. Rhombus show conditionals or decision
processes. Parallelograms show outputs (image acquisition). Circles represent
waiting points, where both inputs have to be reached before proceeding to the
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next step. The left section of the flow chart represent the loading subprocesses, the
middle section the positioning and imaging subprocesses and the right section
shows the unloading subprocess.
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Chapter 4
Vertebrate Automated
Microinjection Platform (VAMP)
4-1 Introduction
Biologics such as nucleic acids [1-3], proteins, cells [4], and
nanoparticles [5] are under active investigation for the treatment of a wide
variety of human diseases. In contrast to chemically synthesized small
molecules, which have precisely defined structures and are typically
engineered with enhanced solubility and permeability [6], biologics generally
have structures that are generally much larger and far more complex, and
therefore require sophisticated modes of delivery. Consequently, although
large libraries of these materials are currently available [7-10], it remains
challenging to rapidly assess their in vivo properties, such tissue specificity,
pharmacokinetics, toxicity, and efficacy, in biologically relevant vertebrate
models.
Zebrafish (Danio rerio) are increasingly used for chemical and genetic
studies, and have the potential to become a powerful pre-clinical model for in
vivo testing biological therapeutics. A unique combination of features,
including small size, optical transparency, and rapid development, make
zebrafish an advantageous vertebrate model for high-throughput screening
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(HTS) [11, 12], which is cost-prohibitive in mammals, and lead to detection of
adverse toxicity and off-target side effects in the early stages of
pharmaceutical development [13, 14]. HTS of small molecules in zebrafish has
identified novel biologically active compounds currently undergoing clinical
trials [15]. Large-scale screening of biologics in zebrafish would offer similar
advantages but is currently limited due to the absence of key technology for
delivery of these materials to targeted organ or tissue of zebrafish. Usually,
such delivery is done by manual microinjection [13], a process that is too slow
and labor-intensive for HTS. Although automated microinjection systems have
been developed for delivering nucleic acids and other agents into the yolk of
pregastrula stage zebrafish embryos [14, 16], there are no existing high-
throughput microinjection methodologies which can be readily applied to
older embryos and larvae for precise targeting of specific organs and tissues.
Here, we demonstrate a vertebrate automated microinjection platform
(VAMP for high-throughput injection and screening of biologic delivery
vehicles in zebrafish larvae. We validated the functionality of VAMP by
screening a library of structurally diverse amino-alkyl-acrylate and -
acrylamide materials (to facilitate mRNA delivery), from which several
formulations were identified to facilitate the delivery and local translation of
protein-encoding mRNA in the central nervous system (CNS) of zebrafish
larvae. These screening results were subsequently shown to be conserved in
vivo in rodents, further validating the utility of the VAMP technology, which
enables a dramatic increase in the throughput and complexity with which in
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vivo assays can be performed. Deployment of VAMP into the screening field
impacts a broad spectrum of both fundamental and translational research.
4-2 System Setup
The vertebrate automated microinjection platform (VAMP) consists of
three major components: microfluidic larva handling, gel-droplet based larva
arraying, and automated microinjection. One screening cycle includes five
consecutive operations to a larva: loading, arraying, orientation/
immobilization, microinjection of testing materials, and recovery of larvae
from gel-droplet arrays (Fig. 4-1). Initially, larvae are kept in E3 media
supplemented with 1% ultralow melting point (LMP) agarose, which remains
liquid phase at room temperature (25 2C) and solidifies at 4 oC. Larvae are
extracted from a 96-well plate with a mesh-filter insert, allowing easy transfer
of larvae into the system [17]. A Light-Emitting Diode/Photodetector pair
monitors the fluid path to discern the entry of larvae into the loading tube
[18]. After loading and photodetection, a syringe pump dispenses each larva
onto a flat pre-treated plate in an array format of single larva containing gel-
droplets. The volume of each droplet is optimized according to array format:
25 pl for 96-spot array and 70 pl 24-spot array. To prevent mixing between
each gel-droplet before solidifying, and also to ensure low contacting angle for
easy imaging, the flat polystyrene plate are plasma treated with protection of a
silicone mask to render 96 or 24 hydrophilic circular regions over a
hydrophobic background, so that the dispensed gel droplets are isolated and
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confined within the 96 or 24 hydrophilic spots. After arraying, the plate with
arrays of single larva containing gel-droplets is transferred onto a temperature
controlled stage with pulse vibrations. To access different organs of zebrafish,
the larvae are placed into two basic orientations. For injecting into dorsal
targets, larvae are agitated with pulses of vibrations, which induces startle
response causing them to assume a dorsal-up orientation(Fig. 4-2a-c). For
injecting into lateral and ventral targets, larvae are anesthetized by addition of
0.2 mg ml-1 tricaine to the 1% LMP agaorse, which causes the larvae to orient
laterally (Fig. 4-2d-f). The dorsal and lateral orientation success rates based
on agitating and aesthesis mechanisms for larvae of 4 day post fertilization
(d.p.f.) are 93.4 ± 6.6% and 84.4 ± 2.9% (Table 4-1, n = 323). With the
application of orientation mechanisms, we demonstrated successful
microinjection of FITC-labeled dextran into different tissues or organs of
larvae, including fore-brain (Fig. 4-2b), ventricle (Fig. 4-2c), eyes (Fig. 4-2d),
heart (Fig. 4-2e) and liver (Fig. 4-2f) [19]
After proper orientation, single larva containing gel-droplets are
solidified by cooling at 4 degrees "C with the temperature control module.
Larvae are therefore immobilized within each gel-droplet. Then, the plate with
larva droplets is transferred onto the automated microinjection platform
consisting of a microinjection module, a long working distance objective with
motorized Z-focus, an XY-axis stage, and a high-speed camera (Fig. 4-1). Using
an in-house developed image recognition software (see Section 4-4), the
system automatically locates each larva within a gel-droplet, positions and
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zooms in the target region (brain ventricle) at the center of field of view. The
injection micropipette is then lowered to approach the target tissue/organ
gradually. The actual penetration of the micropipette tip into the larva is also
determined by the software, which subsequently trigger the injecting
operation. The overall success rate of the automated microinjection is 97.3%
(n = 150), and the average deviation of injection site from the center of
ventricle is 50 ± 26 ptm (distance, s.d., n = 75 from 3 separate experiments).
After microinjection, a self-adhesive bottomless silicone multiwell chamber is
attached to create 96 isolated wells containing the gel-droplets. Each well is
then filled with E3 medium and the larvae are recovered and released by
gentle flushing. It takes 20.0 ± 0.9 seconds to finish a complete cycle of loading,
arraying, orientation, immobilization, automated microinjection and recovery
of each larva, while the processing time can be further improved to 13.1 ± 0.5
seconds per larva with parallel processing (Table 4-2), which is achieved by
independently perform larvae-arraying and microinjection. This is a
significant improvement in the efficiency for handling zebrafish larvae, assays
of similar complexity require about 5 min per larva, and the assays are error-
prone [13]
To evaluate the ability to not affect the health of organisms in VAMP, we
assessed the health of 478 larvae (4 d.p.f.) after running them through the
system, including loading, arraying, orientation, immobilization,
microinjection and recovery. The assessment was based on both functional
and morphological criteria (see Section 4-5). For both survivability and
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abnormality tests, operations by the VAMP show no significant evidence of
adverse effect to the zebrafish larvae health, when comparing experimental set
to control animal set. Notably, the few abnormal larvae in the experimental set
gradually recover in the following few days after operations, and no obvious
difference can be detected between the experimental and control animals 4
days after operations (Fig. 4-3).
4-3 Image Processing and Recognition
Initialization and autofocusing algorithm
For every microinjection cycle, the motorized microscope focuses on the
microinjection tip which points the center of the view. Autofocusing process
follows the initialization step (Fig. 4-4a-c).
For achieving automated microinjection, the first step is autofocusing. When we
compare a focused and a defocused image, the difference between the two
images is situated in the energy content on the higher frequencies in the spatial
domain. Several experiments reveal that a simple high-pass filter for the spatial
domain is sufficient for the desired implementation. The used algorithm is based
on following convolution mask, resulting in the described high-pass characteristic.
The spacing for this high-pass filter is 19.2 ptm. (CCD pixel: 8 lpm, optics: 0.6X,
objective: 2X, Zoom: 2X)
0 -1 0
k =-1 4 -1
0 -1 0
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In order to find the focal plane, scanning through convoluted image value is very
straightforward. In the VAMP system, the position of droplet holding plate is
known and fixed. Therefore the maximum scanning range of the motorized
microscope is not more than 400 pm, and the maximum step number is less than
10. In VAMP, the autofocusing process is only needed to be executed during the
starting point of the system and the process can be limited in 3 seconds.
Head/target recognition algorithm
The head or organs of larva is determined using a threshold-based
algorithm which takes advantages of the recognition of the zebrafish eyes, yolk
and the axis the fish body (Fig. 4-4d). In this algorithm, a threshold is set to
find darkest parts of a larva: eyes and the yolk. After that, the axis of a larva is
measured via rotated image-correlation with a saved template. Then, the
profile of a larva can be determined by the line of centroids of eyes and the
axis. The position of ventricle can be further located via shifting from the
intersection of two lines. The optimal threshold value was determined via the
optimization from distribution histogram. There were many factors that affect
the threshold value and hence the algorithm accuracy, including the intensity
of background light, the use of 1-phenyl 2-thiourea (PTU), the day of larvae
and optical apparatus etc. The major factors were the stability of the light
intensity generated from the power source, the orientation of the zebrafish
larvae, and the agarose droplet size. For the injection process, it was observed
51
that, being oriented with a fixed-frequency vibration motor, all larvae tended
to stay at the same vertical location.
Automated injection
Consequently, the injection process could be performed rapidly using
the predetermined and fixed needle trajectory. Microinjection is the last step in
an automated microinjection cycle (Fig. 4-4f). Two methods are using in this step.
One, based on an ideal controlled condition, the distance between injection
needle tip and the ventricle of a larva is known. And therefore, microinjection can
be done by directly moving a specific distance of the needle. Another method
involves monitoring the image change during the needle pressing on the head
of larva. During the needle-pressing period, the deformation of tissue would
increase the difference between the current and original images. However,
after the needle penetrates tissues, the image difference will decrease rapidly.
Our algorithm identifies the penetration process by detecting the decrease of
image difference. In addition to the automated microinjection system, the
semi-automated system, which allows full control of the needle via computer
keyboard, was implemented in Matlab. Such semi-automated system was used
as a complement to the fully automated system when different injection sites
and extremely high injection precision are desired.
The results represented in Table 4-3 were obtained from the agar-
immobilized zebrafish larvae between 3 and 5 day post fertilization. In this
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experiment, the depository destination was the zebrafish brain. For the
determination of horizontal injection position, the injection site deviation was
found to be 50.1±26.4 prm and it took 1.0 ±0.1 seconds with the success rate of
96%. It was observed that if the algorithm that determined injection location
was repeatedly run multiple times, the accuracy became better with a tradeoff
of longer run time. For the injection process, it took 5.0±0.1 seconds with the
success rate of 97.33%.
4-4 System Hardware Architecture
The system starts by initializing syringe pumps (TECAN), a high-speed camera,
lamps, shutters, position stages (IAI), a manipulator (Eppendorf), an injector
(Sutter), Prior stage, and motors (Nikon). The fluidic valves (Fig. 4-1) are switched
to the direction of flow. The larva is aspirated from the selected 96-well plate with
mesh-insert at a constant rate of acceleration of 42 pl/s2 up to a maximum speed
of 330 pl/s. This 96-well plate is mounted with a temperature control module for
maintaining liquid condition of LMP agarose solution. The photodetector is
continuously sampled at 2 kHz rate via the NiDAQ PCI-6259 card until the intensity
reading crosses a pre-determined threshold (the value of threshold is calibrated in
advance by trial and error). Upon detection of the larva the fluidic valve is
switched to the water/LMP agarose reservoir. The aspiration rate is subsequently
decreased to 83 pl/s to avoid damaging the larva while dispensing and forming a
droplet. Consequently, the Prior X-Y stage moves the distance of a well. After 24
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or 96 droplet array is formed, a temperature control module cools down the plate
to 4 *C for solidifying agarose droplets. Next, the system goes into the
microinjection cycle, as stated in Section 4-3. The high-speed CCD at the top port
is continuously reading at 100 frames/second via a 5X objective lens. The zoom
and focus is controlled automatically via Nikon motorized microscope. The
motorized manipulator that holds the injector with in-house built automated
controller brings the injection needle to the target Z position, and dispenses
solutions into the larva. After injecting, the needle is moved to the original
location. The system is now ready for the next cycle of operation.
4-5 Health Assessment
The syringe was operated at three different initial aspiration rates of 165, 250 and
330 l s-1 for loading 2-d.p.f. larvae from multiwell plates. In total, 450 larvae
were anesthetized with 0.20 mg ml-i tricaine, loaded and dispensed from the
platform. A control group of 150 larvae from the same breed were similarly
anesthetized. Health assessment was based on both functional and morphological
criteria measured. Functional criteria included visual confirmation of normal
heartbeat and reflex response to touch stimuli. Morphology criteria included
bending (that is, lordosis, kyphosis and scoliosis) and craniofacial abnormalities.
Abnormalities were counted even if the zebrafish regenerated later.
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Figures
Automated
Microinjection
System
Figure 4-1. Schematic of the vertebrate automated microinjection system.
Larvae immersed in liquid low-melting-point agarose are automatically loaded
from a multiwell plate into the droplet arrayer and deposited onto a surface-
treated plate. Both the loading and arraying plates are held on motorized x-y
stages and the loading and dispensing nozzles are mounted on motorized z
stages. After being arrayed in a grid, larvae are induced to assume a dorsal-up
orientation by agitating the plate with a vibration motor. The agarose droplets
are then cooled using a thermoelectric cooler to immobilize the larvae. The
automated microinjection system automatically identifies each larva and
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positions the region of interest under the injection needle. A computer-
controlled microinjection module then injects test compounds into the target
tissue. After injection, a self-adhesive bottomless multiwall plate is attached to
the arraying plate and the larvae are recovered from the agarose droplets by
gentle water flushing.
b rc
Vibration motor Cooling module .J2
Figure 4-2. Orientation mechanisms and images of injected fish. (a) Schematic
of self-orientation and immobilization setup. (b)-(f) Images of FITC coupled
dextran microinjection targeting different organs. (b) Microinjection targeting
the fore-brain. (c) Microinjection targeting the ventricle. (d) Microinjection
targeting an eye. (e) Microinjection targeting the heart. (f) Microinjection
targeting the liver. Scale bar, 100 ptm.
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Figure 4-3. Quantitative assessment of zebrafish health after automated
microinjection. (a) Survivability of larvae as a function of days post injection.
(n = 478). (b) Abnormality of larvae as a function of days post processing
(dpp). (n = 478)
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Figure 4-4. Microinjection process cycle. (a) An automated microinjection
cycle consisted of five processes, including (b) initialization, (c) autofocusing,
(d) target recognition, (e) positioning and (f) microinjection. In most of
conditions, autofocusing does not have to be repeated every time, and
therefore indicated with a green arrow.
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Table 4-1. Performance of self-orientation
Orientationpehmdwsm
Dorsal orientation by stimulation
Lateral orientation by anesthetization
Dorsal orientation without stimulation
h = 323
Success rateb (%)
93A± 2.9
13.6± 6.6
60.0± 3.2
Table 4-2. Timeline of system operation
Step
Loading and microdispensing
Positioning
Injecting
Orientation and immobilization in 96-well format
Overall duration for each larva in series
Overall duration for each larva after pipelining
Test samples front-loading
3n = 60 for each
lime t s.d.
(sec/larva)
13.11 0.5
1.0±0.2
5.1 0.1
0.8 ± 0.1
20.0± 0.9
13.1± 0.5
19.9± 6.9
Table 4-3. Performance of automated positioning, image recognition and injection
Process Injection Site Time (s) Success rate* (%)
deviation* (pm)
Injection site recognition 50.1±26.4 1.0±0.1 96.0
and positioning
Injection n/a 5.0±0.1 97.3
Ventricle is 400 gm long
** n =75, each
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Chapter 5
Vertebrate in vivo screening
based on VAMP
5-1 Introduction
To demonstrate the capability of the technology, we screened of a
library of 59 lipid-like materials in searching for vehicles which can facilitate
targeted in vivo delivery of therapeutic gene products [1]. This library of lipid-
like materials was rapidly built using a unique synthetic strategy based on
epoxide chemistry, and is composed of nondegradable amino alcohols
consisting of polar amine-containing head groups and nonpolar hydrocarbon
tails (lipidoids) [1, 2]. Several formulations from the library were identified to
enable siRNA-directed liver gene silencing in mice at low doses[1]. In this
study, the same materials are tested using our VAMP technology, in order to
potentially discover vehicles that can efficiently facilitate the delivery of long
protein-encoding-mRNAs into cells in the central nervous system in vivo. As an
alternative to DNA-based gene therapy, tissue/organ targeted mRNA delivery
could be a new method for delivery of therapeutic proteins [2-5], and had been
a significant challenge due to mRNA's large size and susceptibility to
enzymatic degradation in vivo [6].
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5-2 In vivo Screening of Zebrafish and Validation
To use zebrafish larva as a predicative model for identifying most
effective compound for in vivo mRNA delivery, lipoids in the library were
complexed with mRNA encoding mCherry fluorescent protein at a constant
weight ratio (10:1), and microinjected into the ventricle of each larva using
VAMP. Each larva was administrated at single dose of 10 pg total mRNA. From
this screen, several lipidoids were identified to facilitate in vivo delivery and
expression of mCherry in brain tissue of zebrafish larvae (Fig. 5-1), which is
dificult using the conventional commercially available transfection reagents.
Results demonstrate the extraordinary ability of epoxide lipidoids to
effectively deliver mRNA into cells in zebrafish central nervous system. Each
condition was tested with more than 8 larvae and results indicate no evidence
of toxic effects via health assessment [1]. The experiments follow CAC
protocol 0112-008-15 (Appendix).
Conservancy in Rodent Models. Next, the top three compounds screened
from zebrafish model, C16-62, C16-120, C12-120, and two randomly chose
compounds, C8-100, C10-62, were tested within rodents to investigate
whether the gene-delivery potency of the screened materials is conserved in
mammalian organisms. Single dose of mCherry-encoding mRNA (0.25 pg)
formulated with these materials were stereotaxically injected into the lateral
ventricle of young adult female Sprague Dawley rats (n = 3, each condition)
with 10:1 lipidoid:mRNA weight ratio (Fig. 5-2a). Animals were allowed to
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recover for 48 hours before they were sacrificed and tissue was harvested for
analysis of expression of mCherry protein (see Section 5-3). Interestingly, all
five compounds showed similar relative delivery trends in the rat lateral
ventricle as they do in zebrafish larva with similar potency trend was also
conserved (Fig. 5-2b-d), which was demonstrated by both quantitative
fluorescent imaging of brain slices (Fig. 5-2e), and dot-blotting of proteins
(see Section 5-6) collected from isolated tissue sections (Fig. 5-2f). The
rodent experiments follow the CAC protocol 1011-126-14 (Appendix).
Cell-based Delivery Results on Rodent Primary Neural Cells. To further
investigate the delivery efficacy between in vivo and in vitro assays, selected
lipidoid materials were tested in rodent primary neural cells in vitro. Primary
hippocampal neurons from E18 Sprague Dawley rats were harvested (see
Section 5-4) and plated on Poly-ornithine/Laminin coated plates. 48 hours
after plating, cells transfected by complexing mCherry-encoding mRNA with
lipidoid at weight ratio of 10:1 lipidoid:mRNA and incubated with cells in the
presence of growth media (n = 9, each condition). Via cytotoxicity assay,
selected lipidoid materials were indicated no evidence of adverse effects [1].
Results show a different trend in cell-based delivery compared to in vivo
results (Fig. 5-3). In particular, the best-performing lipidoid C12-100 from in
vitro test, showed poor delivery efficacy in our in vivo screening.
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Results comparison and discussion. From in vivo zebrafish and rodent
assays, similar trends of delivery efficacy can be observed. For example, the
difference of delivery efficiencies from C16-62 and C12-120 in rodents and
zebrafish are both statisitcally significant when comparing with RNA alone,
and between C16-62 and C12-120. The correlation coefficient (Pearson
Product-moment correlation) of the assays between rodent and zebrafish is
0.96, and the correlation between rodent and neuron culture is 0.47. These
results further validate the use of zebrafish as a predictive model for
mammalian animals; and further prove the great potential utility of our VAMP
technology in functional in vivo screening of biologic libraries. Most
surprisingly, when compared to in vivo screening in zebrafish, the in vitro, rat
primary neurons yielded a different predictive pattern, Possibly suggesting
the zebrafish model could be a more predictable model than in vitro assays in
many situations, which also suggest the large potential VAMP can have.
5-3 Ventricle Injection in Rats
Young adult female Sprague-Dawley rats (Charles River) (<350 g) were
anesthetized using isoflurane and injected at stereotaxic coordinates (-3.0 RC -
0.5 ML -15 DV mm). 10 pl of mCherry RNA was injected at a rate of 10 ptl/min.
Wound on rodents was closed and were given post-operative dosages of
buprenorphine and meloxicam. 48 hours following injections animals were
sacrificed and tissue was collected and slices were rapidly taken using a
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Vibratome (now Leica) All animal work was carried out with the approval of
MIT's Committee on Animal Care (CAC) and the Department of Comparative
Medicine (DCM) as well as in accordance with local, state, and federal animal
care guidelines. Note: this experiment was done by Peng Shi and Joseph
Steinmeyer.
5-4 Rodent Primary Neural Cells
Primary neurons were harvested from E18 pups taken from timed-
pregnant Sprague-Dawley rats. Cells were plated at approximately 100,000
per well of Poly-Ornithine/Laminin coated 24 well plates. Cells were cultured
in media composed of 50/50 DMEM/F12, and 0.5X N2 and 0.5X B27 within
Penicillin/Streptomycin for the first 36 hours before antibiotic was removed in
preparation for delivery. Because the presence of antibiotics has been found
to have an adverse effect on lipid-based transfection efficiencies, antibiotic
was removed from the media 12 hours prior to transfections. Note: this
experiment was done by Joseph Steinmeyer.
5-5 Lipidoids-mRNA Formulations
Lipidoid-mRNA formulations for in vivo screening were made from
lipidoid, cholesterol, and a polyethylene glycol modified lipid as described [1]
(15, 18). Stock solutions of lipidoid, cholesterol (MW 387, Sigma-Aldrich), and
mPEG2000-DMG (MW 2660, synthesized by Alnylam) were made in absolute
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ethanol at concentrations of 100, 20, and 100 mg4nL, respectively.
Components were combined to yield weight fractions of 52:20:28. Ethanol
mixture was then added to 200 mM sodium acetate buffer (pH 5) while
stirring to spontaneously form empty liposomes. mRNA at a concentration of
0.25 mg4nL in 50 mM sodium acetate was added to empty liposomes at a
weight ratio of 10:1 total lipids:mRNA and the mixture was incubated at 37 *C
for 30 min. Formulations were then dialyzed against PBS in 3,500 MWCO
dialysis cassettes (Pierce) for 75 min. Following buffer exchange, a sample of
each formulation was used for particle characterization.
5-6 Dot-blot of Rodent Brain Tissues
After collecting tissues around the ventricle region, we go through the
protein extraction process for isolation of proteins by using protein extraction
kit from Millipore, and follow its protocol.
Protein detection using the dot blot protocol is similar to western
blotting in that both methods allow for the identification and analysis of
proteins of interest. Dot blot methodology differs from traditional western blot
techniques by not separating protein samples using electrophoresis. Sample
proteins are instead spotted onto membranes and hybridized with an antibody
probe. Semi-quantitative measurements can be made of the spots. The
procedures is shown in the following paragraph.
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First, label nitrocellulose membrane using a pencil to identify protein
elution fractions. Second, pipette 2 1 from each fraction onto the membrane,
allow the membrane to dry. When dry, incubate the membrane in blocking
solution for 1 hour. After incubation, incubate the membrane with primary
antibody solution (diluted in blocking solution), for 2 hours at room
temperature. And then , wash the membrane in washing buffer (3 x 10 min).
Next, incubate the membrane with secondary antibody-alkaline phosphatase
enzyme conjugate solution (in blocking solution) for 1 hour, prior to wash the
membrane in washing buffer for three times (10 min, each). Consequenctly,
incubate the membrane in substrate solution, until spots are visible. Finally,
stop the reaction by rising in distalled water, and air dry the membrane.
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Figure 5-1. Selected in vivo screening results of lipidoid library on 4 dpf
zebrafish larvae. Low dosage mCherry mRNA was complexed with lipidoids
and injected into ventricles of larvae. (a) Relative expression of
mRNA/lipidoids complex. Expression level is determined by mCherry
fluorescence intensity. Notably, expression from C16-62 is significantly higher
than from the rest of lipidoids. Red arrows indicate lipidoids for rodent assays.
(n = 10, each)
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Figure 5-2. In vivo expression of mCherry-encoding mRNA with the presence
of lipidoids in young adult female rats. (a) Images of a rodent brain slice. Red
box circles the region to image mCherry expression and extract tissues. Scale
bar, 5mm. (b)-(d) Fluorescence images of brain slices from rats with different
injection materials, RNA alone, C16-62 and C16-120. Scale bar, 100 Pm. (e)
mCherry expression measured by fluorescence intensity. The expression from
C16-62 is significantly higher than the rest of lipidoids. (c) A representative
dot-blot image shows the similar mCherry expression trends measured by
fluorescence intensity. (n=3, each)
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Figure 5-3. In vitro assay on rodent primary neural cells. The expression
efficacy is measured by mCherry fluorescent intensity. The top three delivery
compounds are C 12-100, C16-120 and C 12-112, which shows a different trend
of delivery when compare to in vivo in zebrafish and in rodents.
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Chapter 6
Conclusions
Currently, the majority of screening process starts from high-throughput in
vitro assays and further validate via mammalian rodent models. However,
validating these in vivo preliminary hits made by in vitro drug screening by
mammalian animal models is significantly slow and costly, resulting in a gap in the
drug development process. Furthermore, the predictability of cell-based models
for advanced animal models is frequently challenged. The zebrafish is a vertebrate
model organism holds a great potential to bridge this gap [1-3]. In fact, zebrafish is
known as one of the most ideal animal models for in vivo high-throughput
screening [4]. The trend of zebrafish studies is also growing exponentially.
In this Ph.D work, the author has built high-throughput screening technologies
for zebrafish larvae for the first time, including Vertebrate Automated Screening
Technology (VAST), Pipelining VAST and Vertebrate Automated Microinjection
Platform (VAMP). A screen of the library of lipidoid compounds has been
performed to validate the capability of these technologies. Furthermore,
mammalian rodent experiments and in vitro assays have been done for examining
zebrafish model as an ideal animal model for predicting advanced animal models
in a high-throughput fashion.
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Results of this work expand the possibility for zebrafish model to bridge
cell-based assays and rodent models because of the high-throughput and low-cost
advantages from our technologies as well as its high predictability for rodent
models. To further unfold the capability of zebrafish model, the author suggests
focusing on the following directions.
Automated microinjection for cell delivery. Delivery of cells into zebrafish holds a
great potential to offer a screening model between in vitro and in vivo assays. It
may unleash the possibility of new methodologies for different studies such as
stem cell differentiation, cancer cell studies etc. Although some works have been
done to show the advantages of cell-delivery based assays [5], cell-delivery
techniques are quite challenging because of cell stickiness. Actually, delivery of
cells into zebrafish is a challenge even for manual injection. Our VAMP has been
shown with the great capability for soluble compound and material injection. It
significantly eases the efforts researchers have to do as well as reduce the needs
of knowledge and skills for microinjection. To extend the ability of VAMP, reduce
the painfulness of microinjection and increase the throughput, it will be an
important function VAMP could have in the future.
Connections between VAST and VAMP. Currently, the connection between VAST
and VAMP is via manual transportation, which limits the power of in vivo-TAP
technology. To achieve the goal of a highly automated in vivo high-throughput
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screening platform, one of the key priorities is to allow VAST and VAMP
connecting to each other in an automated fashion. In fact, with this technology, an
unmanned in vivo screening platform will be expectable.
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